• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有脊柱骨质疏松症男性的骨量及骨代谢生化指标

Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis.

作者信息

Resch H, Pietschmann P, Woloszczuk W, Krexner E, Bernecker P, Willvonseder R

机构信息

Department of Medicine, Krankenhaus Barmherzige Brüder, Vienna, Austria.

出版信息

Eur J Clin Invest. 1992 Aug;22(8):542-5. doi: 10.1111/j.1365-2362.1992.tb01503.x.

DOI:10.1111/j.1365-2362.1992.tb01503.x
PMID:1425860
Abstract

With advancing age both sexes have an increased incidence of osteoporotic fractures, although fractures are more common in women than in men. Whereas in women several potential risk factors have been identified, less is known about osteoporosis in men. A total of 27 Austrian men (mean age: 65 +/- 2 years) with atraumatic spine fractures were studied. In all patients, medical history gave no evidence of disease or medications causing osteoporosis. Peripheral bone mass was determined by single-photonabsorptiometry on the distal non-dominant forearm; lumbal bone density was measured by quantitative computed tomography. Serum levels of calcium, phosphate, alkaline phosphatase, osteocalcin, testosterone, estrogen, parathyroid hormone and 25-hydroxy-vitamin D as well as 2-h-urinary-OH proline and calcium excretion were measured. All data were compared with those of an age and sex matched control group consisting of 19 healthy males. A significant difference in mean peripheral and axial bone mass (SPA: P less than 0.004; QCT: P less than 0.0001) was observed between osteoporotic men and controls. When compared to controls, serum levels of alkaline phosphatase (P less than 0.012), urinary OH proline (P less than 0.05) and urinary calcium excretion (P less than 0.003) were significantly higher in the osteoporotic males. Additionally, there was a significant positive correlation between serum alkaline phosphatase and urinary OH proline excretion (r = 0.32; P less than 0.04) in the osteoporotics. All other biochemical parameters showed no significant differences. Our results may lead to the assumption that osteopenia in men is related to increased bone turnover.

摘要

随着年龄的增长,骨质疏松性骨折的发病率在两性中均有所上升,尽管女性骨折比男性更为常见。虽然已确定女性存在多种潜在风险因素,但对于男性骨质疏松症的了解却较少。本研究共纳入了27名患有非创伤性脊柱骨折的奥地利男性(平均年龄:65±2岁)。所有患者的病史均未显示有导致骨质疏松症的疾病或药物。通过单光子吸收法测量非优势侧远端前臂的外周骨量;通过定量计算机断层扫描测量腰椎骨密度。检测血清钙、磷、碱性磷酸酶、骨钙素、睾酮、雌激素、甲状旁腺激素和25-羟基维生素D水平,以及2小时尿羟脯氨酸和钙排泄量。所有数据均与由19名健康男性组成的年龄和性别匹配的对照组进行比较。观察到骨质疏松男性与对照组之间在外周和轴向骨量方面存在显著差异(单光子吸收法:P<0.004;定量计算机断层扫描:P<0.0001)。与对照组相比,骨质疏松男性的血清碱性磷酸酶水平(P<0.012)、尿羟脯氨酸水平(P<0.05)和尿钙排泄量(P<0.003)显著更高。此外,骨质疏松患者血清碱性磷酸酶与尿羟脯氨酸排泄之间存在显著正相关(r = 0.32;P<0.04)。所有其他生化参数均无显著差异。我们的结果可能导致这样一种假设,即男性骨质减少与骨转换增加有关。

相似文献

1
Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis.患有脊柱骨质疏松症男性的骨量及骨代谢生化指标
Eur J Clin Invest. 1992 Aug;22(8):542-5. doi: 10.1111/j.1365-2362.1992.tb01503.x.
2
High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.心脏移植受者骨质疏松症的高患病率以及生化转换标志物与骨组织形态计量学之间的不一致性。
Clin Endocrinol (Oxf). 1999 Mar;50(3):347-55. doi: 10.1046/j.1365-2265.1999.00657.x.
3
Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women.早期健康与晚期骨质疏松绝经后女性维生素D代谢的比较。
Calcif Tissue Int. 1990 Dec;47(6):332-7. doi: 10.1007/BF02555883.
4
Vitamin D Deficiency and Its Influence on Bone Metabolism and Density in a Brazilian Population of Healthy Men.维生素D缺乏及其对巴西健康男性群体骨代谢和骨密度的影响。
J Clin Densitom. 2018 Jan-Mar;21(1):91-97. doi: 10.1016/j.jocd.2017.01.008. Epub 2017 Feb 21.
5
Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption.男性年龄相关性(II型)股骨颈骨质疏松症:维生素D缺乏和雄激素缺乏所致骨吸收的生化证据
J Bone Miner Res. 1997 Dec;12(12):2119-26. doi: 10.1359/jbmr.1997.12.12.2119.
6
Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis.维生素D不足会增加已确诊椎体骨质疏松症患者的骨转换标志物,并加剧其髋部骨质流失。
Clin Endocrinol (Oxf). 1999 Aug;51(2):217-21. doi: 10.1046/j.1365-2265.1999.00764.x.
7
Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.胰岛素依赖型糖尿病中的骨质减少;患病率及病理生理学方面
J Endocrinol Invest. 2000 May;23(5):295-303. doi: 10.1007/BF03343726.
8
Urinary calcium excretion and bone turnover in osteoporotic patients
.骨质疏松症患者的尿钙排泄与骨转换
Clin Nephrol. 2017 Nov;88(11):239-247. doi: 10.5414/CN109144.
9
Effects of norethisterone on bone related biochemical variables and forearm bone mineral in post-menopausal osteoporosis.炔诺酮对绝经后骨质疏松症骨相关生化指标及前臂骨矿物质的影响。
Clin Endocrinol (Oxf). 1993 Dec;39(6):649-55. doi: 10.1111/j.1365-2265.1993.tb02422.x.
10
Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.选择性雌激素受体调节剂(盐酸雷洛昔芬)对绝经后骨质疏松症治疗中白细胞介素-6、肿瘤坏死因子-α、转化生长因子-β1及骨转换标志物的影响
Eur Cytokine Netw. 2007 Sep;18(3):148-53. doi: 10.1684/ecn.2007.0097. Epub 2007 Sep 7.

引用本文的文献

1
Secondary confounders of osteoporotic hip fractures in patients admitted to a geriatric acute care department.老年急性护理科收治患者骨质疏松性髋部骨折的次要混杂因素。
Z Gerontol Geriatr. 2015 Oct;48(7):633-40. doi: 10.1007/s00391-014-0821-8. Epub 2014 Nov 25.
2
Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures.日本患有骨质疏松症或骨质减少症且有骨折临床风险因素的男性接受阿仑膦酸盐治疗7年的经验。
Clin Rheumatol. 2016 Jan;35(1):205-12. doi: 10.1007/s10067-014-2812-y. Epub 2014 Nov 1.
3
Heterogeneity of biological bone markers in idiopathic male osteoporosis.
特发性男性骨质疏松症中生物骨标志物的异质性。
Rheumatol Int. 2012 Jul;32(7):2101-4. doi: 10.1007/s00296-011-1930-y. Epub 2011 Apr 17.
4
Gender aspects of osteoporosis and bone strength.骨质疏松症与骨强度的性别因素
Wien Med Wochenschr. 2011 Mar;161(5-6):117-23. doi: 10.1007/s10354-011-0891-9.
5
Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures.日本骨质疏松或骨量减少症伴有骨折临床风险因素的男性患者使用阿伦膦酸盐治疗四年的经验。
Ther Clin Risk Manag. 2010 Dec 6;6:593-600. doi: 10.2147/TCRM.S15812.
6
Comparison of the effects of alendronate and alfacalcidol on hip bone mineral density and bone turnover in Japanese men having osteoporosis or osteopenia with clinical risk factors for fractures.比较阿仑膦酸钠和阿法骨化醇对伴有骨折临床危险因素的日本骨质疏松或骨量减少男性髋部骨密度和骨转换的影响。
Yonsei Med J. 2009 Aug 31;50(4):474-81. doi: 10.3349/ymj.2009.50.4.474. Epub 2009 Aug 19.
7
Osteoporosis in men.男性骨质疏松症
Endocr Rev. 2008 Jun;29(4):441-64. doi: 10.1210/er.2008-0002. Epub 2008 May 1.
8
Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis.阿仑膦酸钠对男性和绝经后骨质疏松症女性腰椎骨密度及骨转换影响的比较。
Clin Rheumatol. 2007 Feb;26(2):161-7. doi: 10.1007/s10067-006-0252-z. Epub 2006 Mar 25.
9
Unresolved issues in osteoporosis in men.男性骨质疏松症的未解决问题。
Rev Endocr Metab Disord. 2001 Jan;2(1):45-64. doi: 10.1023/a:1010054924085.
10
Age-related changes in bone density among healthy Greek males.健康希腊男性骨密度的年龄相关变化。
J Endocrinol Invest. 2001 May;24(5):326-33. doi: 10.1007/BF03343869.